Luca M. Di Tommaso

Vessels encapsulating tumor clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab.

Journal: JHEP reports : innovation in hepatology

Published: February 28, 2026

Heterogeneity of pathological tumour response in patients with multiple colorectal liver metastases undergoing resection after preoperative chemotherapy.

Journal: ESMO open

Published: January 13, 2026

A confidence-based, artificial intelligence pathology model for diagnosis of intrahepatic cholangiocarcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 22, 2025

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 24, 2025

Multimodal Phasor Analysis for Digital Pathology: Quantitative Characterization of Liver Iron Overload.

Journal: Chemical & biomedical imaging

Published: November 12, 2025

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Journal: Molecular cancer

Published: October 17, 2025

Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of Treatment.

Journal: Liver cancer

Published: September 18, 2025

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Journal for immunotherapy of cancer

Published: August 31, 2025

Loss of hormone receptor expression in breast tissue following pre-surgical therapy with an SERD.

Journal: Histopathology

Published: August 11, 2025

New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.

Journal: JHEP reports : innovation in hepatology

Published: August 04, 2025

Digital Histopathology and AI: A New Era of Liver Fibrosis Quantification.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Vessels encapsulating tumor clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab.

Vessels encapsulating tumor clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab.

Heterogeneity of pathological tumour response in patients with multiple colorectal liver metastases undergoing resection after preoperative chemotherapy.

Heterogeneity of pathological tumour response in patients with multiple colorectal liver metastases undergoing resection after preoperative chemotherapy.

A confidence-based, artificial intelligence pathology model for diagnosis of intrahepatic cholangiocarcinoma.

A confidence-based, artificial intelligence pathology model for diagnosis of intrahepatic cholangiocarcinoma.

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing.

Optimized Ex Vivo Human Liver Slice Culture Maintains Extended Viability and Function for Hepatotoxicity Testing.

Multimodal Phasor Analysis for Digital Pathology: Quantitative Characterization of Liver Iron Overload.

Multimodal Phasor Analysis for Digital Pathology: Quantitative Characterization of Liver Iron Overload.

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Multi-omics profiling reveals divergent biology and liver microenvironment in HCC of metastatic and de novo origin.

Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of Treatment.

Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of Treatment.

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Loss of hormone receptor expression in breast tissue following pre-surgical therapy with an SERD.

Loss of hormone receptor expression in breast tissue following pre-surgical therapy with an SERD.

New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.

New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.

Digital Histopathology and AI: A New Era of Liver Fibrosis Quantification.

Digital Histopathology and AI: A New Era of Liver Fibrosis Quantification.

Reply: Diagnostic accuracy of ChatGPT-4 and liver fibrosis in MASH.

Reply: Diagnostic accuracy of ChatGPT-4 and liver fibrosis in MASH.